HEPATIC FIBROSIS, MEASURED BY FIBROSCANIN A GROUP OF PATIENTS WITH OBESITY
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2012, Vol 19, Issue 2
Abstract
Introduction. Hepatic steatosis is a reversible condition caused by accumulation of triglycerides in liver cells. Non-alcoholic fatty liver disease (NAFLD) can progress to advanced liver disease: fibrosis, cirrhosis, liver failure, cancer, and finally can lead to death; therefore NAFLD contributes significantly to morbidity and mortality of hepatic cause. Materials and methods: The study was conducted on a group of 88 patients with Body Mass Index (BMI) ≥ 30kg/m², they were excluded patients with known diabetes. Results, Discussion: The statistical analysis showed that in more than half of subjects elastometry values were higher than those considered normal, obesity is a risk factor for NAFLD that progresses in hepatic fibrosis. Conclusions: Liver fibrosis is present in high percentage in patients with obesity (52% of subjects) and it was positively correlated with age, arterial stiffness and fasting glucose.
Authors and Affiliations
Raluca Costina Dina, Maria Mota, Iulia Vladu, Ciprian Dina
Keywords
Related Articles
- EP ID EP94059
- DOI 10.2478/v10255-012-0016-2
- Views 103
- Downloads 0
THE ASSOCIATION BETWEEN ADIPONECTIN, LEPTIN, PROINFLAMMATORY MARKERS AND METABOLIC SYNDROME IN OBESE, NONDIABETIC SUBJECTS
The aim of this study was to evaluate the association between adipokines (adiponectin and leptin), inflammatory markers, insulin resistance and metabolic syndrome in obese, non-diabetic subjects. Methods: Thirty three ob...
MANAGEMENT OF HYPERTENSION IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE
Diabetes mellitus and hypertension are the most common causes of end-stage renal disease. Blood pressure goals in patients with diabetic kidney disease are <130/80 mmHg. The first line therapy for hypertension in thes...
DIABETES MELLITUS EPIDEMIOLOGY
The worldwide diabetes epidemics is evolving proportionally with the overweight/obesity epidemics. 246 million people with diabetes (type 2 diabetes constituting about 90%) were registered worldwide in 2007. It was estim...
PANCREATIC BETTA CELL CLOCK AND TELOCYTES
RESISTIN AND HIGH GLUCOSE CONCENTRATIONS-ACTIVATION OF HUMAN SMOOTH MUSCLE CELLS INDUCES ENHANCED MONOCYTE CHEMOTAXIS